S. Grüner

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Sabine Grüner, S. Grüner, Sabine Grüner, S Grüner, S. Grüner
Publication record
43 papers · 3,636 citations · H-index 20

PAPERS

STING activation induces polarized cytokine secretion of IFN-β and IL-17A promoting photoreceptor death and choroidal disruption in age-related macular degeneration.
20260 citationsauthor #9
A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies
20243 citationsauthor #5
Development of PRS-400, an inhaled Jagged-1 Anticalin protein for the treatment of muco-obstructive lung diseases
20222 citationsauthor #10
Efficacy of simultaneous VEGF‐A/ANG‐2 neutralization in suppressing spontaneous choroidal neovascularization
201959 citationsauthor #3
P36 CATHEPSIN-S INHIBITION HAS A DUAL THERAPEUTIC EFFECT ON THE SYSTEMIC AND PERIPHERAL PATHOMECHANISMS OF LUPUS NEPHRITIS
20160 citationsauthor #4
Subretinal injection of poly(IC) causes acute photoreceptor cell death in the mouse retinal detachment model
20160 citationsauthor #2
Novel Triazolopyrimidine‐Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases
201651 citationsauthor #7
Quantitative assessment of vessel regression and pericyte detachment in a mouse model of retinal angiogenesis
20160 citationsauthor #3
Inside Cover: Novel Triazolopyrimidine‐Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases (ChemMedChem 2/2016)
20160 citationsauthor #7
Highly potent and selective cannabinoid receptor 2 agonists: initial hit optimization of an adamantyl hit series identified from high-through-put screening.
201311 citationsauthor #4
High throughput transcriptome analysis of lipid metabolism in Syrian hamster liver in absence of an annotated genome
201310 citationsauthor #6
adhesion at sites of arterial injury in vivo Multiple integrin-ligand interactions synergize in shear-resistant platelet
20130 citationsauthor #2
anti-GPVI antibodies in mice Relative antithrombotic effect of soluble GPVI dimer compared with
20131 citationsauthor #3
eNOS Protects from Atherosclerosis Despite Relevant Superoxide Production by the Enzyme in apoE−/− Mice
201292 citationsauthor #4
An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes.
2011117 citationsauthor #6
Plaque Progression in the ApoE-/- Mouse Model of Atherosclerosis Monitored in Three Vascular Beds
20090 citationsauthor #2
Abstract: 563 ROLE OF NNOS IN ATHEROSCLEROSIS
20090 citationsauthor #3
Rheology of Coating Materials and Their Coating Characteristics
20080 citationsauthor #2
Diminished lymphocyte adhesion and alleviation of allergic responses by small-molecule- or antibody-mediated inhibition of L-selectin functions.
200726 citationsauthor #4
Abstract 236: Endothelial Nitric Oxide Production Inhibits Leukocyte Endothelial Cell- But Not Platelet Endothelial Cell Interactions
20070 citationsauthor #4
Extraction of active ingredients from green tea (Camellia sinensis): Extraction efficiency of major catechins and caffeine
2006495 citationsauthor #6
Defective thrombus formation in mice lacking coagulation factor XII
2005724 citationsauthor #3
Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice.
200598 citationsauthor #1
Abstracts of papers presented at the XIXth European Platelet Meeting, 14th–16th October 2004, Dorint Resort & Spa, Bad Brückenau, Germany
20051 citationsauthor #3
Unresponsiveness of Platelets Lacking Both Gαq and Gα13
200459 citationsauthor #3
Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice.
2004147 citationsauthor #2
Unresponsiveness of platelets lacking both Galpha(q) and Galpha(13). Implications for collagen-induced platelet activation.
200432 citationsauthor #3
Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
200457 citationsauthor #1
Anti–Glycoprotein VI Treatment Severely Compromises Hemostasis in Mice With Reduced &agr;2&bgr;1 Levels or Concomitant Aspirin Therapy
200492 citationsauthor #1
Relative antithrombotic effect of soluble GPVI dimer versus anti-GPVI antibodies in mice Running title: Antithrombotic effect of soluble GPVI dimer
20040 citationsauthor #1
Anti–Glycoprotein VI Treatment Severely Compromises Hemostasis in Mice With Reduced (cid:1) 2 (cid:2) 1 Levels or Concomitant Aspirin Therapy
20040 citationsauthor #1
Anti–Glycoprotein VI Treatment Severely Compromises Hemostasis in Mice With Reduced 2 1 Levels or Concomitant Aspirin Therapy
20044 citationsauthor #1
Turn liquids into powders using the patented CPF Technology
20030 citationsauthor #1
Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo.
2003142 citationsauthor #1
Reversed-phase HPLC determination of mangiferin, isomangiferin and hesperidin in Cyclopia and the effect of harvesting date on the phenolic composition of C. genistoides
200364 citationsauthor #3
Die Rolle der Thrombozyten- und Leukozyten-Endothelzell-Interaktion in der Atherogenese
20033 citationsauthor #1
Recruitment of Chlamydia pneumoniae–Infected Macrophages to the Carotid Artery Wall in Noninfected, Nonatherosclerotic Mice
200341 citationsauthor #3
Targeting of the collagen-binding site on glycoprotein VI is not essential for in vivo depletion of the receptor.
200368 citationsauthor #5
G13 is an essential mediator of platelet activation in hemostasis and thrombosis
2003261 citationsauthor #5
CPF: Concentrated powder form- technology: Problem solutions for instable systems. Part I. Production of fluid penetrated particles with CPF-Technology
20030 citationsauthor #1
Role of β3-endonexin in the regulation of NF-κB-dependent expression of urokinase-type plasminogen activator receptor
200216 citationsauthor #6
A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation
2002935 citationsauthor #3
G 13 is an essential mediator of platelet activation in hemostasis and thrombosis
year unknown27 citationsauthor #5

TIMELINE

2002 951 citations

2003 579 citations

2004 391 citations

2005 823 citations

2006 495 citations

2007 26 citations

2008 0 citations

2009 0 citations

2011 117 citations

2012 92 citations

2013 22 citations

2016 51 citations

2019 59 citations

2022 2 citations

2024 3 citations

2026 0 citations

Unknown 27 citations

S. Grüner

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT